Enrolling By InvitationNCT06179485
Effect of Ketamine and Etomidate During RSI on Long Term Outcomes
Observational studyAges 18+United StatesPTSD
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Birmingham and 5 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 6, 2022
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 1,756
- Sponsor
- Vanderbilt University Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06179485
- Official title
Show the full official title
Effect of Ketamine and Etomidate During Rapid Sequence Intubation on Long- Term Outcomes (Long-Term Outcomes of the RSI Trial)
Recruitment & locations
By invitationThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · Aurora · Denver
3 more locations
- Minneapolis
- Winston-Salem
- Nashville
Questions about this study
Who is behind this study?
The study sponsor is Vanderbilt University Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including ketamine and Etomidate.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
